US2900415A
(en)
|
1954-12-14 |
1959-08-18 |
Lakeside Lab Inc |
Synthesized antispasmodic compounds
|
CH481110A
(de)
|
1967-02-17 |
1969-11-15 |
Geigy Ag J R |
Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
|
CH498122A
(de)
|
1968-02-09 |
1970-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
|
CH500194A
(de)
|
1968-02-15 |
1970-12-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung von Tetrahydroazepinderivaten
|
GB1268243A
(en)
|
1968-03-11 |
1972-03-22 |
Wallace & Tiernan Inc |
0,2,4,5,-tetrahydro-3h,3-benzazepines
|
US4233217A
(en)
|
1968-03-11 |
1980-11-11 |
Pennwalt Corporation |
Substituted 1,2,4,5-tetrahydro-3H, 3 benzazepines
|
FR314F
(ja)
|
1968-03-22 |
1970-05-25 |
|
|
FR7736M
(ja)
|
1968-09-02 |
1970-03-09 |
|
|
US3716639A
(en)
|
1970-03-11 |
1973-02-13 |
Ciba Geigy Corp |
Anorexigenic tetrahydrobenzazepines
|
US3795683A
(en)
|
1970-08-19 |
1974-03-05 |
Hoffmann La Roche |
2,3,4,5-tetrahydro-1h-3-benzazepines
|
LU65954A1
(ja)
|
1972-08-25 |
1974-03-07 |
|
|
US4210749A
(en)
|
1974-11-12 |
1980-07-01 |
Pennwalt Corporation |
Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
|
SE7510988L
(sv)
|
1975-10-01 |
1977-04-02 |
Draco Ab |
Nya farmaceutiskt aktiva foreningar
|
DE2627479C2
(de)
|
1976-06-18 |
1983-09-22 |
Bergwerksverband Gmbh, 4300 Essen |
Verwendung eines Formkokses als Adsorptionsmittel für Schwefeloxide aus Abgasen
|
US4111957A
(en)
|
1977-02-02 |
1978-09-05 |
Smithkline Corporation |
Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
|
US4108989A
(en)
|
1977-04-01 |
1978-08-22 |
Smithkline Corporation |
2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones
|
DE2758001A1
(de)
|
1977-12-24 |
1979-07-12 |
Hoechst Ag |
Cephalosporinderivate und verfahren zu ihrer herstellung
|
CA1090797A
(en)
|
1978-06-20 |
1980-12-02 |
Kenneth G. Holden |
Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1h- 3-benzazepine compounds
|
AU515236B2
(en)
|
1978-06-26 |
1981-03-26 |
Smithkline Corporation |
Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives
|
ZA792785B
(en)
|
1978-07-07 |
1980-08-27 |
Smithkline Corp |
Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
|
IE50355B1
(en)
|
1979-10-20 |
1986-04-02 |
Wyeth John & Brother Ltd |
Morpholine derivatives
|
US4477378A
(en)
|
1980-02-05 |
1984-10-16 |
Schering Corp. |
Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
|
ZA827887B
(en)
|
1981-11-27 |
1983-11-30 |
Smithkline Beckman Corp |
Pharmaceutical compositions and method of producing alpha2 antagonism
|
DE3272044D1
(de)
|
1981-11-27 |
1986-08-21 |
Smithkline Beckman Corp |
3-benzazepines as alpha-2 antagonists
|
FR2518544A1
(fr)
|
1981-12-22 |
1983-06-24 |
Lipha |
Benzodiazepines-1,3 thione-2, procede de preparation et medicament les contenant
|
FR2525603A1
(fr)
|
1982-04-27 |
1983-10-28 |
Adir |
Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique
|
US4988690A
(en)
|
1982-06-14 |
1991-01-29 |
Hoechst-Roussel Pharmaceuticals Inc. |
1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
|
DE3418270A1
(de)
|
1984-05-17 |
1985-11-21 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
US4541954A
(en)
|
1984-09-05 |
1985-09-17 |
Smithkline Beckman Corporation |
Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
|
EP0204349A3
(de)
|
1985-06-01 |
1990-01-03 |
Dr. Karl Thomae GmbH |
Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
GB8610668D0
(en)
|
1986-05-01 |
1986-06-04 |
Pfizer Ltd |
Anti-arrhythmia agents
|
EG18188A
(en)
|
1986-05-01 |
1992-09-30 |
Pfizer Ltd |
Process for preparation anti-arhythmia agents
|
US4762845A
(en)
|
1986-05-21 |
1988-08-09 |
Abbott Laboratories |
7-(3-Substituted imino-1-pyrrolidinyl)-quinolone-3-carboxylic acids
|
EP0285287A3
(en)
|
1987-03-23 |
1990-08-16 |
Smithkline Beecham Corporation |
3-benzazepine compounds for use in treating gastrointestinal motility disorders
|
US5247080A
(en)
|
1987-03-27 |
1993-09-21 |
Schering Corporation |
Substituted benzazepines useful as intermediates for producing pharmaceutically active compounds
|
US5015639A
(en)
|
1987-03-27 |
1991-05-14 |
Schering Corporation |
Substituted benzazepines, their preparation and pharmaceutical compositions containing them
|
ZA882080B
(en)
|
1987-03-27 |
1989-04-26 |
Schering Corp |
Substituted benzazepines,their preparation and pharmaceutical compositions containing them
|
AU1700688A
(en)
|
1987-04-09 |
1988-11-04 |
Smithkline Beckman Corporation |
Sulfinyl and sulfonyl substituted 3-benzazepines
|
US4957914A
(en)
|
1987-05-15 |
1990-09-18 |
Syntex (U.S.A.) Inc. |
1,9-alkano-bridged-2,3,4,5-tetrahydro-1H-3-benzazepines
|
DK107688D0
(da)
|
1988-03-01 |
1988-03-01 |
Novo Industri As |
Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
|
US5422355A
(en)
|
1989-06-02 |
1995-06-06 |
John Wyeth & Brother, Limited |
Composition for treating depression with (N-heteroaryl)alkylamines
|
US5178786A
(en)
|
1989-08-04 |
1993-01-12 |
The Lubrizol Corporation |
Corrosion-inhibiting compositions and functional fluids containing same
|
MTP1076B
(en)
|
1990-01-12 |
1991-09-30 |
Ciba Geigy Ag |
Hemihydrate
|
EP0513174B1
(en)
|
1990-02-02 |
1995-08-16 |
Schering Corporation |
4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
|
CA2037162A1
(en)
|
1990-03-12 |
1991-09-13 |
Steven Howard Shaber |
Heterocyclicacetonitriles and fungicidal use
|
WO1991019698A1
(en)
|
1990-06-15 |
1991-12-26 |
Schering Corporation |
8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substitued benzazepines and pharmaceutical compositions containing them
|
US5275915A
(en)
|
1991-06-05 |
1994-01-04 |
Dainippon Ink And Chemicals, Inc. |
Developer for light-sensitive material
|
JPH06508352A
(ja)
|
1991-06-21 |
1994-09-22 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
門脈圧亢進症および片頭痛の治療用のテトラヒドロベンズアゼピン誘導体の使用
|
GB9116824D0
(en)
|
1991-08-05 |
1991-09-18 |
Smithkline Beecham Corp |
Chemical compounds
|
EP0558824A1
(en)
|
1992-02-04 |
1993-09-08 |
Duphar International Research B.V |
Method for the preparation of vicinal aminoalcohols and optically active O-protected derivatives thereof
|
US5241065A
(en)
|
1992-02-25 |
1993-08-31 |
Schering Corporation |
2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
|
JPH05339263A
(ja)
|
1992-06-08 |
1993-12-21 |
Wakunaga Pharmaceut Co Ltd |
ジヒドロピリジン誘導体
|
JP2987258B2
(ja)
|
1992-07-13 |
1999-12-06 |
沖電気工業株式会社 |
非同期転送モード通信網におけるトラヒック監視方式
|
JPH06298746A
(ja)
|
1993-04-19 |
1994-10-25 |
Showa Denko Kk |
環状イミド酸エステルの製造法
|
CA2166100A1
(en)
|
1993-06-23 |
1995-01-05 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
US5387685A
(en)
|
1993-07-16 |
1995-02-07 |
American Cyanamid Co |
MDR reversal agents
|
GB9322976D0
(en)
|
1993-11-08 |
1994-01-05 |
Pfizer Ltd |
Therapeutic agents
|
DE4419246A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
|
DE4419247A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
|
DE4419315A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
|
DE4427838A1
(de)
|
1994-08-05 |
1996-02-08 |
Thomae Gmbh Dr K |
Kondensierte Azepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
DE4429079A1
(de)
|
1994-08-17 |
1996-02-22 |
Thomae Gmbh Dr K |
Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
JPH08134048A
(ja)
|
1994-11-08 |
1996-05-28 |
Sumitomo Chem Co Ltd |
オキサゾリン類の製造法
|
DE19510566A1
(de)
|
1995-03-23 |
1996-09-26 |
Kali Chemie Pharma Gmbh |
Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
GB9508622D0
(en)
|
1995-04-28 |
1995-06-14 |
Pfizer Ltd |
Therapeutic agants
|
US5958543A
(en)
|
1995-07-07 |
1999-09-28 |
Stor Media,Inc. |
Micro-texturing for sputtered, thin film magnetic media disks utilizing titanium sputtered in the presence of hydrogen to form micro-texturing
|
JPH0930960A
(ja)
|
1995-07-18 |
1997-02-04 |
Takasago Internatl Corp |
真菌感染症治療剤
|
CA2190708A1
(en)
|
1995-12-08 |
1997-06-09 |
Johannes Aebi |
Aminoalkyl substituted benzo-heterocyclic compounds
|
US5892116A
(en)
|
1996-01-03 |
1999-04-06 |
Georgetown University |
Gelators
|
US5925651A
(en)
|
1996-04-03 |
1999-07-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5691362A
(en)
|
1996-06-05 |
1997-11-25 |
Schering-Plough Corporation |
Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
|
WO1998006701A1
(en)
|
1996-08-15 |
1998-02-19 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
WO1998040385A1
(en)
|
1997-03-07 |
1998-09-17 |
Novo Nordisk A/S |
4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
|
AUPP020297A0
(en)
|
1997-11-05 |
1997-11-27 |
University Of Melbourne, The |
A novel receptor, and compounds which bind thereto
|
EP1067109B1
(en)
|
1998-03-10 |
2009-12-09 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid derivatives and drugs containing the same as the active ingredient
|
JP3603177B2
(ja)
|
1998-03-26 |
2004-12-22 |
参天製薬株式会社 |
新規ウレア誘導体
|
CN1305846C
(zh)
|
1998-03-26 |
2007-03-21 |
参天制药株式会社 |
脲衍生物
|
EP0987235B1
(en)
|
1998-08-25 |
2003-03-12 |
MERCK PATENT GmbH |
Method for the conversion of arenes or alkenes with iodoalkenes, aryl iodides or arenediazonium salts
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
US20080255093A1
(en)
|
1999-06-14 |
2008-10-16 |
Tam Peter Y |
Compositions and methods for treating obesity and related disorders
|
ATE254614T1
(de)
|
1999-08-06 |
2003-12-15 |
Hoffmann La Roche |
Tetrahydro-benzo(d)azepine und deren verwendung als metabotrope glutamatrezeptor-antagonisten
|
EP1074549B1
(en)
|
1999-08-06 |
2003-11-19 |
F. Hoffmann-La Roche Ag |
Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
|
JP2001076413A
(ja)
|
1999-09-06 |
2001-03-23 |
Sony Corp |
フレキシブル磁気ディスク用ヘッドスライダー
|
US6403657B1
(en)
|
1999-10-04 |
2002-06-11 |
Martin C. Hinz |
Comprehensive pharmacologic therapy for treatment of obesity
|
DE10003708A1
(de)
|
2000-01-28 |
2001-08-02 |
Solvent Innovation Gmbh |
Neuartige chirale ionische Flüssigkeiten und Verfahren zu ihrer Darstellung in enantiomerenreiner oder enantiomerenangereicherter Form
|
BR0111947A
(pt)
|
2000-06-30 |
2003-05-06 |
Glaxo Group Ltd |
Composto, composição farmacêutica, método para o tratamento de um distúrbio em um mamìfero, uso de um composto e processo para preparar, um composto
|
EP1335915B1
(en)
|
2000-11-14 |
2008-01-02 |
Smithkline Beecham Plc |
Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
|
DE10057751A1
(de)
|
2000-11-22 |
2002-05-23 |
Bayer Ag |
Neue Carbamat-substituierte Pyrazolopyridinderivate
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
WO2002074746A1
(fr)
|
2001-03-16 |
2002-09-26 |
Yamanouchi Pharmaceutical Co., Ltd. |
Derives de benzazepine
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
US7550261B2
(en)
|
2001-08-21 |
2009-06-23 |
Smithkline Beecham Corporation |
Method of screening for drug hypersensitivity reaction
|
US20060100196A1
(en)
|
2001-09-24 |
2006-05-11 |
Andrea Gailunas |
Substituted amines for the treatment of alzheimer's disease
|
EP1456178A1
(en)
|
2001-12-21 |
2004-09-15 |
Smithkline Beecham Plc |
7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
|
WO2003057161A2
(en)
|
2001-12-28 |
2003-07-17 |
Bayer Pharmaceuticals Corporation |
BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF
|
JP2005519915A
(ja)
|
2002-01-18 |
2005-07-07 |
セレテック・リミテッド・ライアビリティ・カンパニー |
Edg受容体に関連する症状の処置方法
|
ATE486842T1
(de)
|
2002-03-12 |
2010-11-15 |
Merck Sharp & Dohme |
Substituierte amide
|
US6953787B2
(en)
|
2002-04-12 |
2005-10-11 |
Arena Pharmaceuticals, Inc. |
5HT2C receptor modulators
|
WO2003086303A2
(en)
|
2002-04-12 |
2003-10-23 |
The University Of Chicago |
Farnesoid x-activated receptor agonists
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
GB0224557D0
(en)
|
2002-10-22 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
DE10261131A1
(de)
|
2002-12-20 |
2004-07-01 |
Grünenthal GmbH |
Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
EP2332920A3
(en)
|
2003-06-17 |
2011-12-21 |
Arena Pharmaceuticals, Inc. |
Processes for preparing 3-benzazepines
|
PL2332921T3
(pl)
|
2003-06-17 |
2016-08-31 |
Arena Pharm Inc |
Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny
|
CA2529750A1
(en)
|
2003-06-20 |
2005-02-24 |
Arena Pharmaceuticals, Inc. |
N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
|
TW200510324A
(en)
|
2003-08-11 |
2005-03-16 |
Lilly Co Eli |
6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
|
US20080009478A1
(en)
|
2003-10-22 |
2008-01-10 |
Arena Pharmaceuticals, Inc. |
Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
|
US20070275949A1
(en)
|
2003-10-22 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases
|
PL1720836T3
(pl)
|
2004-02-25 |
2014-09-30 |
Lilly Co Eli |
6-podstawione 2,3,4,5-tetrahydro-1h-benzo [d]azepiny jako agoniści receptora 5-ht2c
|
US7157445B2
(en)
|
2004-02-26 |
2007-01-02 |
Aventis Pharma S.A. |
Administration of enoxaparin sodium to patients with severe renal impairment
|
SE0401871D0
(sv)
|
2004-07-15 |
2004-07-15 |
Glucogene Medical Hfm Ab |
New compositions
|
MX2007001337A
(es)
|
2004-08-02 |
2008-03-13 |
Genmedica Therapeutics Sl |
Compuestos para inhibir amina-oxidasas que contienen cobre y usos de los mismos.
|
US8178077B2
(en)
|
2004-10-19 |
2012-05-15 |
Reverse Proteomics Research Institute Co., Ltd. |
Drug development target protein and target gene, and method of screening
|
NZ555981A
(en)
|
2004-12-21 |
2011-01-28 |
Arena Pharm Inc |
Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
|
NZ555482A
(en)
*
|
2004-12-23 |
2011-01-28 |
Arena Pharm Inc |
Compositions comprising a 5HT2C receptor modulator and 2-methylamphetamine and methods of use
|
EP2471779A1
(en)
|
2006-04-03 |
2012-07-04 |
Arena Pharmaceuticals, Inc. |
Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
|
ES2522587T3
(es)
|
2006-12-05 |
2014-11-17 |
Arena Pharmaceuticals, Inc. |
Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
|
EP2164324B1
(en)
|
2007-06-15 |
2014-08-13 |
University Of Florida Research Foundation |
Therapeutic compounds
|
CA2709861A1
(en)
|
2007-12-20 |
2009-07-02 |
Neurosearch A/S |
Pharmaceutical compositions
|
WO2009097416A1
(en)
|
2008-01-29 |
2009-08-06 |
Vanda Pharmaceuticals, Inc. |
Imidazolylalkyl- pyridines as dbh inhibitors
|
WO2009111004A1
(en)
|
2008-03-04 |
2009-09-11 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
|
US7608616B1
(en)
|
2008-06-03 |
2009-10-27 |
Questcor Pharmaceuticals, Inc. |
Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
|
US8952197B2
(en)
|
2009-06-18 |
2015-02-10 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of 5-HT2C receptor agonists
|
KR20180118801A
(ko)
|
2010-09-01 |
2018-10-31 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태
|
CN103347523A
(zh)
|
2010-09-01 |
2013-10-09 |
艾尼纳制药公司 |
向具有肾损伤的个体给药氯卡色林
|
MX2013002430A
(es)
|
2010-09-01 |
2013-07-22 |
Arena Pharm Inc |
Formas de dosis de disolucion de rápida de agonistas de 5-ht2c.
|
CA2808909A1
(en)
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
Salts of lorcaserin with optically active acids
|
WO2012030953A1
(en)
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
|
CN102126988A
(zh)
|
2010-12-17 |
2011-07-20 |
张家港瀚康化工有限公司 |
4-(4-氯苯基)-2-溴甲基-2-苯基丁腈的制备方法
|